Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
160.1 USD | +0.26% | +2.83% | +29.04% |
Business Summary
Number of employees: 229
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 0 | nan % | 51 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 51 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 14/04/16 | |
Suma M. Krishnan
FOU | Founder | 59 | 14/04/16 |
Ram Kamineni
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/22 |
Trevor Parry
CTO | Chief Tech/Sci/R&D Officer | - | - |
George Chen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Meg Dodge
IRC | Investor Relations Contact | - | - |
Hubert Chen
PRN | Corporate Officer/Principal | - | - |
John Thomas
LAW | General Counsel | - | 31/08/21 |
Nate Rattner
AUD | Comptroller/Controller/Auditor | - | - |
John Karakkal
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Janney
BRD | Director/Board Member | 58 | 31/10/16 |
Suma M. Krishnan
FOU | Founder | 59 | 14/04/16 |
Dino Rossi
BRD | Director/Board Member | 69 | 31/05/17 |
Chief Executive Officer | 59 | 14/04/16 | |
Julian Gangolli
BRD | Director/Board Member | 66 | 28/02/19 |
Director/Board Member | 57 | 31/08/17 | |
E. Sutherland
BRD | Director/Board Member | 54 | 17/01/22 |
Director/Board Member | 66 | 03/01/21 | |
Director/Board Member | 59 | 05/03/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,514,547 | 24,871,222 ( 87.22 %) | 0 | 87.22 % |
Company contact information
Krystal Biotech, Inc.
2100 Wharton Street Suite 701
15203, Pittsburgh
+412 586 5830
http://www.krystalbio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.04% | 4.55B | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- KRYS Stock
- Company Krystal Biotech, Inc.